EnjoSim Medical key facts
- Developer of self-administration systems designed to support the drug and device needs of patients.
- Notable investors include Addor Capital, Grandway Capital, Luminous Ventures, Moutai (Guizhou) Private Equity Fund Management, Tachem — 6 tracked in total.
- Status: Privately Held (backing).
- ·Watch EnjoSim Medical: the Monday email on marks, rounds and moves
EnjoSim Medical funding rounds
No funding rounds for EnjoSim Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
EnjoSim Medical investors
6 investors are on record for EnjoSim Medical, including Addor Capital, Grandway Capital, Luminous Ventures and Moutai (Guizhou) Private Equity Fund Management.
About EnjoSim Medical
Developer of self-administration systems designed to support the drug and device needs of patients. The company offers high-precision pen injection devices adapted to biological agents such as insulin, GLP-1, growth hormone, and follicle-stimulating hormone, thereby enabling patients to with clinical needs to self-administer medicine at home with self-injection pens.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- enjosim.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
EnjoSim Medical doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.